Sheridan County Jail Launches Wyoming's First Medication-Assisted Treatment Program for Incarcerated Individuals

The Sheridan County Detention Center has launched Wyoming's first medication-assisted treatment (MAT) program for incarcerated individuals, marking a significant shift in how the state's criminal justice system addresses substance use disorders. As of early May, 22 participants were actively enrolled, with 21 having initiated treatment while in custody—a milestone in a state where rural isolation and limited healthcare infrastructure have long hindered addiction recovery efforts.

The program, which began accepting participants earlier this year, provides buprenorphine alongside counseling and educational components. It represents a recognition that jails, which have become de facto detox facilities across rural America, can serve as intervention points rather than mere waystations in the cycle of addiction and incarceration.

A First for Wyoming

Wyoming's geographic vastness and sparse population have created persistent challenges for addiction treatment. The state consistently ranks among those with the highest rates of substance use disorders and lowest availability of treatment providers. Within this context, the Sheridan County program breaks new ground as the first jail-based MAT initiative in the state.

Sheridan County Undersheriff Ben Miller, who helped shepherd the program's development, noted the facility's unique position. "We're not just holding people here—we're in a position to actually help them," Miller said in an interview with local media. "If we can get someone stable on medication and connected to services before they leave, we might break the cycle that's been repeating for years."

The program's structure reflects evidence-based practices that have shown promise in other jurisdictions. Participants receive buprenorphine, a partial opioid agonist that reduces cravings and withdrawal symptoms without producing the euphoria associated with full opioid agonists like heroin or fentanyl. Alongside medication, participants engage in counseling sessions that address the psychological and behavioral dimensions of addiction.

Education as Foundation

A distinctive element of the Sheridan County program is its emphasis on education. Program coordinator Dr. Sarah Ackerman, who oversees clinical operations, has structured the curriculum to help participants understand the neurobiological basis of addiction.

"MAT is not a 'quick fix,'" Ackerman emphasized. "We break it down so they can see why it happens, how their brain works, what the medication does, and how they can help themselves."

This educational approach addresses a common barrier to MAT acceptance: the misconception that medication simply substitutes one addiction for another. By explaining the pharmacological differences between buprenorphine and full opioid agonists, the program aims to reduce stigma and increase participant engagement.

The curriculum also covers practical skills for maintaining recovery after release, including strategies for managing triggers, navigating social situations where drug use may be present, and accessing continuing care in the community.

The Context: Jails as Intervention Points

Nationally, the intersection of addiction and incarceration has reached crisis proportions. An estimated 65% of the U.S. jail population meets criteria for substance use disorder, with opioid use disorder particularly prevalent. For many individuals, jail represents the first point of contact with any form of healthcare in years.

Traditional jail protocols have typically managed opioid withdrawal through supportive care—fluids, rest, and monitoring—without pharmacological intervention. This approach, while preventing immediate medical complications, does little to address the underlying addiction and often sets individuals up for immediate relapse upon release.

The period immediately following release from incarceration carries particularly high overdose risk. Tolerance to opioids decreases rapidly during periods of abstinence, meaning that doses that were previously manageable can become fatal. Studies have shown that individuals released from correctional facilities are between 10 and 40 times more likely to die of an opioid overdose in the first two weeks after release compared to the general population.

Jail-based MAT programs aim to address this risk by initiating treatment during incarceration and ensuring continuity of care after release. Rather than forcing individuals through withdrawal only to release them with unchanged cravings and reduced tolerance, these programs seek to stabilize participants on medication and connect them to community providers.

Rural Challenges and Opportunities

Wyoming's rural character shapes both the need for and implementation of the Sheridan County program. The state has fewer than 600,000 residents spread across nearly 98,000 square miles, creating vast treatment deserts where the nearest medication provider may be hours away.

For individuals released from the Sheridan County jail, continuing MAT in the community requires overcoming these geographic barriers. The program has established partnerships with local healthcare providers to ensure that participants can maintain their medication regimens after release, though transportation and appointment access remain ongoing challenges.

The rural setting also affects staffing. Recruiting and retaining healthcare providers with addiction medicine expertise is difficult in any setting but particularly so in remote areas with limited professional networks and amenities. The Sheridan County program relies on a combination of local providers and telemedicine consultations to deliver comprehensive care.

Broader Implications for Wyoming

The Sheridan County initiative arrives as Wyoming grapples with escalating overdose deaths driven primarily by fentanyl. While the state has historically had lower opioid overdose rates than many parts of the country, the synthetic opioid's potency and low cost have rapidly changed the landscape.

State policymakers have taken notice of the jail program's early success. Discussions are underway about expanding MAT access in other correctional facilities, though funding and staffing constraints present significant obstacles. Wyoming's correctional system, like many rural states', operates with limited resources and faces competing priorities.

The program also intersects with broader debates about criminal justice reform and public health approaches to addiction. Traditional law enforcement perspectives have often viewed addiction as a moral failing warranting punishment rather than a medical condition requiring treatment. The Sheridan County program represents a pragmatic middle ground—acknowledging that individuals have committed crimes while recognizing that addressing their addiction serves both humanitarian and public safety goals.

Looking Forward

With 22 participants enrolled and preliminary outcomes promising, the Sheridan County program is positioned to serve as a model for other Wyoming jurisdictions considering similar initiatives. The program's success will ultimately be measured not in enrollment numbers but in longer-term outcomes: rates of recidivism, sustained engagement with treatment after release, and—most importantly—lives saved from overdose.

For the 21 individuals who began treatment while incarcerated, the program offers something that jail traditionally does not: a genuine opportunity for change. Whether that opportunity translates into lasting recovery depends on factors beyond the jail's walls—community support, housing stability, employment opportunities, and continued access to medication.

The Sheridan County Detention Center has taken an important first step. The path ahead remains challenging, but for a state long underserved by addiction treatment infrastructure, any step forward is significant.

---

If you or someone you know is struggling with opioid addiction, help is available. Visit SAMHSA's treatment locator or call 1-800-662-4357. For more information about medication-assisted treatment, explore our guide to buprenorphine and opioid addiction treatment.